Material safety data sheet

Click Bond - CB200 Adhesive - Material Safety Data Sheet
1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION
Product Name: CB200
Product Use/Class: ADHESIVE
EMERGENCY TELEPHONE #: (800) 255-3924 (CHEM•TEL) OUTSIDE NORTH AMERICA #: (813) 248-0585 CALL COLLECT PREPARED BY: Engineering Dept. (775) 885-8000 2. COMPOSITION/INFORMATION ON INGREDIENTS
Less Than TLV-TWA TLV-STEL PEL-TWA PEL-Ceiling Methacrylate phosphate ester Proprietary N.A. – Not Applicable, N.E. - Not Established, S - Skin Designation 3. HAZARDS IDENTIFICATION
*** EMERGENCY OVERVIEW ***: Off-white Liquid, with Sweet odor (Component B) and White Paste, with No odor
(Component A). Flammable liquid. Harmful if absorbed through skin. May cause allergic skin reaction. Causes skin and eye
irritation. Causes respiratory tract irritation.
EFFECTS OF OVEREXPOSURE - EYE CONTACT: Causes eye irritation.
EFFECTS OF OVEREXPOSURE - SKIN CONTACT: May be absorbed through the skin in harmful amounts. Causes
skin irritation. May cause skin sensitization. May cause dermatitis. May cause allergic skin reaction.
EFFECTS OF OVEREXPOSURE - INHALATION: Causes respiratory tract irritation. May cause headache and nausea.
EFFECTS OF OVEREXPOSURE - INGESTION: Harmful if swallowed. Ingestion is not an expected route of entry in
industrial or commercial uses.
EFFECTS OF OVEREXPOSURE - CHRONIC HAZARDS: May cause liver or kidney damage. Chronic skin contact
may cause dermatitis. Prolonged or repeated contact may result in dermatitis.
IARC has designated titanium dioxide (TiO2) as Group 2B - possibly carcinogenic to humans in dust form. However, a
number of long term animal studies and human epidemiology studies evaluating TiO2 and workplace exposure show
insufficient evidence for carcinogenic affects. EPA, NTP and OSHA do not designate TiO2 as a carcinogen and ACGIH
designates TiO2 as A4 - not classifiable as a human carcinogen. TiO2 is not present in this product as a dust and no airborne
exposure is expected during application.
Contains N,N-Dimethylaniline. Excessive overexposure by skin absorption or ingestion may result in anoxia due to the
formation of methemoglobin. This condition impairs the blood's ability to transport oxygen. ACGIH considers molybdenum
to be an A3 carcinogen (confirmed animal carcinogen with unknown relevance in humans).
PRIMARY ROUTE (S) OF ENTRY: Skin Contact, Skin Absorption, Inhalation, Ingestion, Eye Contact
4. FIRST AID MEASURES
FIRST AID - EYE CONTACT: Flush eyes immediately with large amount of water for at least 15 minutes holding eyelids
open while flushing. Get prompt medical attention.
FIRST AID - SKIN CONTACT: Flush contaminated skin with large amounts of water while removing contaminated
clothing. Wash affected skin areas with soap and water. Get medical attention if symptoms occur.
FIRST AID - INHALATION: Move person to fresh air. Restore and support continued breathing. If breathing is difficult,
give oxygen. Get immediate medical attention.
FIRST AID - INGESTION: If swallowed, do not induce vomiting. Give victim one or two glasses of water or milk
(Component A only). Call a physician or poison control center immediately for further instructions. Never give anything by
mouth if victim is rapidly losing consciousness, unconscious or convulsing.
CB200 MSDS Rev. 9
Page 1 of 4
5. FIRE-FIGHTING MEASURES
Component A:
FLASH POINT: 201°F, 93°C (Setaflash Closed Cup)
LOWER EXPLOSIVE LIMIT (%): Not Applicable
AUTOIGNITION TEMPERATURE: N.D.
UPPER EXPLOSIVE LIMIT (%):
Component B:
FLASH POINT: 65°F, 18°C (Setaflash Closed Cup)
LOWER EXPLOSIVE LIMIT (%): 1% (V)
AUTOIGNITION TEMPERATURE: N.D.
UPPER EXPLOSIVE LIMIT (%):
Components A and B:
EXTINGUISHING MEDIA: Carbon Dioxide, Dry Chemical, Foam, Water Fog
UNUSUAL FIRE AND EXPLOSION HAZARDS: Flammable liquid and vapor. Keep containers tightly closed. Isolate
from heat, electrical equipment, sparks, open flame, and other sources of ignition. Closed containers may rupture when
exposed to extreme heat. Use water spray to keep fire exposed containers cool. During a fire, irritating and/or toxic gases and
particulate may be generated by thermal decomposition or combustion.
SPECIAL FIREFIGHTING PROCEDURES: Wear full firefighting protective clothing, including self-contained breathing
apparatus (SCBA). If water is used, fog nozzles are preferable.
6. ACCIDENTAL RELEASE MEASURES
STEPS TO BE TAKEN IN CASE MATERIAL IS RELEASED OR SPILLED: Keep non-essential personnel a safe
distance away from the spill area. Remove all sources of ignition (flame, hot surfaces, and electrical, static, or frictional
sparks). Avoid breathing vapors. Use self-contained breathing equipment. Notify appropriate authorities if necessary. Avoid
contact. Using non-sparking tools, scoop the spilled material into an appropriate container for proper disposal. (If necessary,
use inert absorbent material to aid in containing the spill.)
7. HANDLING AND STORAGE
HANDLING: Keep closure tight and container upright to prevent leakage. Ground and bond containers when transferring
material. Avoid skin and eye contact. Wash thoroughly after handling. Avoid breathing of vapor or spray mists. Do not handle
until all safety precautions have been read and understood. Use with adequate ventilation. Because empty containers may
retain product residue and flammable vapors, keep away from heat, sparks, and flame; do not cut, puncture, or weld on or near
the empty container. Empty containers should not be re-used. Do not smoke where this product is used or stored.
STORAGE: Refer to OSHA 29CFR Part 1910.106 "Flammable and Combustible Liquids" for specific storage requirements.
Store only in well-ventilated areas. Keep container closed when not in use.
8. EXPOSURE CONTROLS/PERSONAL PROTECTION
ENGINEERING CONTROLS: Sufficient ventilation in pattern and volume should be provided in order to maintain air
contaminant levels below recommended exposure limits. Sufficient ventilation (using explosion-proof equipment) should be
provided to prevent flammable vapor/air mixtures from accumulating.
RESPIRATORY PROTECTION: Contains a small amount of dimethylaniline (DMA) which has poor odor-warning
properties. If the exposure limit for DMA is exceeded, an air-supplied respirator is recommended. Otherwise, a properly-fitted
NIOSH approved air-purifying organic vapor respirator is recommended. For emergency situations, confined space use, or
other conditions where exposure limits may be greatly exceeded, use an approved air-supplied respirator. Observe OSHA
regulations (29CFR 1910.134) for respirator use.
SKIN PROTECTION: Use neoprene, nitrile, or rubber gloves to prevent skin contact. If contact with the product is
prolonged or repeated, Silver Shield or Butyl rubber gloves are recommended.
EYE PROTECTION: Use safety eyewear including safety glasses with side shields and chemical goggles where splashing
may occur.
OTHER PROTECTIVE EQUIPMENT: Use disposable or impervious clothing if work clothing contamination is likely.
Remove and wash contaminated clothing before reuse.
HYGIENIC PRACTICES: Wash hands before eating, smoking, or using toilet facility. Food or beverages should not be
consumed anywhere this product is handled or stored. Wash thoroughly after handling.
CB200 MSDS Rev. 9
Page 2 of 4
9. PHYSICAL AND CHEMICAL PROPERTIES
Component A:
DENSITY, LB/GL
: 10.00 lb/gal
VOLATILE BY WEIGHT : 5.98%
APPEARANCE
VAPOR PRESSURE
VOLATILE BY VOLUME : 7.45%
PHYSICAL STATE
VAPOR DENSITY
: Heavier than Air
BOILING RANGE : 100°C
SOLUBILITY IN H2O : Insoluble
FREEZE POINT
ODOR THRESHOLD : N.D.
EVAPORATION RATE : Not Applicable
COEFFICIENT OF WATER/OIL DISTRIBUTION: N.D.
(see section 16 for abbreviation legend) Component B:
DENSITY, LB/GL
: 8.69 lb/gal
VOLATILE BY WEIGHT : 0.0%
APPEARANCE
: Off-white
VAPOR PRESSURE
VOLATILE BY VOLUME : 0.0%
PHYSICAL STATE
VAPOR DENSITY
: Heavier than Air
BOILING RANGE : N.A.
SOLUBILITY IN H2O : Insoluble
FREEZE POINT
ODOR THRESHOLD : N.D.
EVAPORATION RATE : Faster than n-butyl-acetate
COEFFICIENT OF WATER/OIL DISTRIBUTION: N.D.
(see section 16 for abbreviation legend) 10. STABILITY AND REACTIVITY
CONDITIONS TO AVOID: Storage above 100°F and below 32°F. Exposure to sunlight, ultraviolet light irradiation. Avoid
dropping or puncture of containers. High temperatures.
INCOMPATIBILITY: Inorganic acids, organic acids, caustics, oxidizing agents, amines, peroxides, water, hydroxyl, or
active hydrogen compounds.
HAZARDOUS DECOMPOSITION PRODUCTS: Carbon monoxide, carbon dioxide, oxides of nitrogen, aldehydes.
HAZARDOUS POLYMERIZATION: Hazardous polymerization will not occur under normal conditions.
STABILITY: Product is stable under normal storage conditions.
11. TOXICOLOGICAL INFORMATION
PRODUCT LD50 (ORAL): No data
PRODUCT LD50 (DERMAL): No data
PRODUCT LC50: No data
12. ECOLOGICAL INFORMATION
ECOLOGICAL INFORMATION: No information
13. DISPOSAL CONSIDERATIONS
DISPOSAL METHOD: Disposal should be done in accordance with Federal (40CFR Part 261), state, and local
environmental control regulations. If waste is determined to be hazardous, use licensed hazardous waste transporter and
disposal facility.
14. TRANSPORTATION INFORMATION
DOT PROPER SHIPPING NAME: Adhesives
DOT UN/NA NUMBER: 1133
PACKING GROUP: II
DOT HAZARD CLASS: 3
EMERGENCY RESPONSE GUIDE NUMBER: 128
SECONDARY HAZARD: None
The listed transportation classification applies to US DOT non-bulk road shipments. It does not address regulatory variations due to changes in package size, mode of shipment or other regulatory descriptors. For the most accurate shipping information, refer to your transportation/compliance department. CB200 MSDS Rev. 9
Page 3 of 4
15. REGULATORY INFORMATION
U.S. FEDERAL REGULATIONS: AS FOLLOWS -
This product is considered hazardous as defined by 29 CFR 1910.1200 (OSHA HazCom Standard). SARA SECTION 313
This product contains the following substances subject to the reporting requirements of Section 313 of Title III of the Superfund Amendment and Reauthorization Act of 1986 and 40 CFR part 372: Chemical Name
CAS Number
Weight % Less Than
TOXIC SUBSTANCES CONTROL ACT:
INVENTORY STATUS
The chemical substances in this product are on the TSCA Section 8 Inventory. EXPORT NOTIFICATION
This product contains the following chemical substances subject to the reporting requirements of TSCA 12(B) if exported from the United States: 16. OTHER INFORMATION
HMIS RATINGS - HEALTH: 2*
* - indicates a chronic hazard; see section 3 VOLATILE ORGANIC COMPOUNDS
NOTE: In normal use, the acrylate monomer in this product is considered to be non-volatile and is polymerized during cure. For purposes of air quality regulations, the maximum amount of VOC emitted is less than 5%. Actual emissions are a function of processing conditions. VOC is evaluated in combination with CB200 component A. LEGEND: N.A. - Not Applicable, N.E. - Not Established, N.D. - Not Determined
DISCLAIMER: The information contained herein is, to the best of our knowledge and belief, accurate. However, since the
conditions of handling and use are beyond our control, we make no guarantee of results, and assume no liability for damages
incurred by use of this material. It is the responsibility of the user to comply with all applicable federal, state, and local laws
and regulations.
CB200 MSDS Rev. 9
Page 4 of 4

Source: http://www.clickbond.info/files/Documents/cb200_msds.pdf

Black box warnings in prescription drug labeling:

Black Box Warnings in Prescription Drug Labeling: Results of a Survey of 206 Drugs Prescription drugs are unavoidably associated with adverse effects, but the ben-efits of using such drugs outweigh the accompanying risks so long as the expert judg-ment of a licensed practitioner is first applied in the decision to use a drug for aparticular patient. Most risks for prescription drugs appear

Microsoft word - aqha multiple medication violation system _mvs_.docx

AQHA MULTIPLE MEDICATION VIOLATION SYSTEM (MMVS) 1. The AQHA Multiple Medication Violations System (MMVS) sets forth penalties for trainers, owners and horses subject of positive drug tests, and, in particular, is designed to assess penalties against trainers, owners and horses subject of multiple positive drug tests. This system is for AQHA’s use only and is not intended to be a subst

© 2010-2014 Pdf Medical Search